Benzodiazepine consumption Mental and Behavioural Disorders Benzodiazepine consumption
Conditions
Interventions
Health centers enrolled in the study are randomly assigned to a intervention or a control group.
1. Intervention group: All GPs working in one of the intervention health centers attend a two hours wor
Sponsors
Primary Care Management of Mallorca (Gerencia de Atención Primaria de Mallorca)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All GPs from the health centers where the trials will be implemented
Exclusion criteria
Exclusion criteria: Unwillingness to participate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total GP Doses per 1000 Habitants per Day (DHD) of benzodiazepine at 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Percentage of total long term benzodiazepine users at 12 months, measured via information about patient prescribed benzodiacepine for a period longer than six months registered in the prescription database of the electronic health records 2. Percentage of patient older than 65 long term benzodizepine users at 12 months, measured via information about patient older than 65 with a prescription of benzodiazepine registered in the prescription database of the electronic health records 3. Feasibility, adoption and fidelity of the intervention will be measured by an "ad hoc" questionnaire to measure GP opinion | — |
Countries
Spain
Outcome results
None listed